SARS-CoV-2 Mpro-IN-20
SARS-CoV-2 Mpro-IN-20 (compound MPI100) is a SARS-CoV-2 main protease inhibitor. SARS-CoV-2 Mpro-IN-20 shows antiviral activity with the EC50 of 3.4 μM[1].
Product Specifications
UNSPSC
12352005
Target
SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/sars-cov-2-mpro-in-20.html
Smiles
O=C(N1[C@H](C(N[C@@H](C[C@H]2C(NCC2)=O)C=O)=O)[C@@]3([H])C(C)(C)[C@@]3([H])C1)[C@@H](NC(OCC4=CC=CC=C4)=O)CC5CCCCC5
Molecular Formula
C32H44N4O6
Molecular Weight
580.71
References & Citations
[1]Blankenship LR, et al. SARS-CoV-2 Main Protease Inhibitors That Leverage Unique Interactions with the Solvent Exposed S3 Site of the Enzyme. ACS Med Chem Lett. 2024;15 (6) :950-957. Published 2024 May 20.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
More Discoveries
Explore Other Products
Browse additional items from our catalog
K3099405 3x 1.0 µg
Vmn2r27 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse)
Sign In for Pricing
View Details 
034996-ML550 100 µL
EIF2S1, NT (EIF2S1, EIF2A, Eukaryotic translation initiation factor 2 subunit 1, Eukaryotic translation initiation factor 2 subunit alpha) (MaxLight 550) discontinued
Sign In for Pricing
View Details 
SC330477 10 µg
TEA domain family member 2 (TEAD2) (NM_001256662) Human Untagged Clone
Sign In for Pricing
View Details